ADD-ON MULTIPLE SUBMUCOSAL INJECTIONS OF RNA OLIGONUCLEOTIDE GUT-1 TO TUMOR NECROSIS FACTOR-ANTAGONIST TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: AN INVESTIGATOR-INITIATED TRIAL

Kenji Suzuki  ¹     Yukinori Sameshima  ²     Junji Yokoyama  ²     Shuji Terai  ²     Hiroyuki Yoneyama  ³     Raja Atreya  ⁴     Markus F. Neurath  ⁵     Toshifumi Hibi  ⁶     Hitoshi Asakura  ^6    
1 Niigata University Medical and Dental Hospital, Niigata, Japan
² Sameshima Hospital, Kagoshima, Japan
³ GUT Inc., Kochi, Japan
⁴ University Erlangen-Nuremberg, Erlangen, Germany
⁵ University of Erlangen-Nuremberg, Erlangen, Germany
⁶ Kitasato University, Tokyo, Japan

Topic
IBD

Session
Medical therapy in IBD: A potpourri of options (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)